Endarterectomy vs Stenting in Chinese Asymptomatic Carotid Stenosis Patients
NCT ID: NCT03737175
Last Updated: 2018-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
600 participants
INTERVENTIONAL
2018-03-30
2021-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis
NCT05623904
Revascularization of Extracranial Carotid Artery Stenosis
NCT01994187
Efficacy and Prognosis of Surgical Intervention in Patients With Carotid Artery Stenosis
NCT06222983
Carotid Artery Stent Implantation in the Treatment of Vulnerable Plaque
NCT05524207
Ultrasound Evaluation of Carotid Artery Atherosclerotic Plaques and Recanalization
NCT03786666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Carotid Artery Stenting group
Carotid Artery Stenting
Carotid Artery Stenting
Carotid Artery Stenting
Carotid Endarterectomy group
Carotid Endarterectomy
Carotid Endarterectomy
Carotid Endarterectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carotid Artery Stenting
Carotid Artery Stenting
Carotid Endarterectomy
Carotid Endarterectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Age≥50 years，sex unlimited；
2. Asymptomatic carotid stenosis ，ie no transient ischemic attack、stroke or other related neurological symptom caused by carotid stenosis in the past 6 months.(Only the clinical manifestations of dizziness or mild headache are considered asymptomatic carotid stenosis.)；
3. The patient understands the trial objective，understands and accepts the duration of the study，is able and willing to comply with all requirements，including follow-up and evaluation of it, voluntarily participates in the study and signs Informed Consent Form.
Anatomy Criteria
4. Internal carotid artery independent disease.（ Involving or not involving adjacent common carotid arteries is permitted.）；
5. Carotid stenosis satisfies one of the following criteria ：
1. Ultrasonography suggests stenosis ≥ 70%，or angiography showed stenosis ≥ 60%；
2. Ultrasonography suggests stenosis \< 70%，but angiography or other examination showed stenosis in an unstable state；
6. Patients with bilateral carotid stenosis, the treatment time for target vessel contralateral vessels is required 30 days before enrollment or 30 days after completion of study procedure；
7. The stent can reach the site of lesion smoothly as expected.
Exclusion Criteria
1. Patients with progressive stroke in the past 3 months or recent (Within 7 days)， CT or MRI suggested that the lesion is large，and may be with the risk of hemorrhagic transformation；
2. Patients with anesthesia contraindications；
3. Serious ipsilateral stroke occurred in the past and may confuse the judgment of the study endpoint；
4. Patients with severe dementia；
5. Patients with spontaneous intracerebral hemorrhage in the past 12 months；
6. Large size of cerebral infarction or myocardial infarction occurred within 30 days ；
7. Patients with large intracranial aneurysms (diameter\> 5mm)，and cannot be treated in advance or contemporaneous；
8. Chronic total occlusion without obvious cerebral ischemia symptoms；
9. Hemoglobin \<100 g/l， Platelet count \<125×109/L， INR\>1.5， Bleeding time \> 1 min，patients with exceeding the upper limits of normal，or heparin-related thrombocytopenia；
10. Patients unable to perform normal angiographic evaluation or unsafe percutaneous puncture point；
11. Patients with neurologic disorder that caused transient or permanent neurological deficits within 2 years before the surgery and can not be identified with transient ischemic attack or stroke；
12. Patients with other cardiac emboli sources, such as left ventricular aneurysm, intraluminal filling defect, cardiomyopathy, aortic or mitral prosthetic heart valve, calcific aortic stenosis, infective endocarditis, mitral stenosis, atrial septal defect, atrial septal aneurysm, or left atrial myxoma；
13. Recent gastrointestinal bleeding and affects antiplatelet therapy；
14. Surgical contraindications or patients with high risk of surgery defined as having any of the following： It is known that two or more proximal or main coronary artery stenosis ≥70%, untreated or unable to pass； Ejection fraction \<30% or New York Heart Association (NYHA) functional class III or higher； Unstable angina，ie angina at resting state and electrocardiogram changes； Currently waiting main organ transplants (ie heart, lung, liver, kidney), or are doing relevant evaluate； Malignant tumor or respiratory insufficiency, life expectancy \< 5 years or forced expiratory volume at one second \< 30% (predicted)； Dialysis-dependent renal failure； Poor control of diabetes, fasting blood glucose \>22mmol/L and ketone body \> +2； Need to perform other general anesthesia during the same period；
15. There may be one or more anatomical conditions affecting the normal operative approach in patients with contraindications for carotid endarterectomy operation； there may be one or more anatomic situations to increase the risk of adverse events in patients with high operative risk；including： Neck radiation therapy history； Radical neck surgery history； Inoperable lesions (ie more than C2 lesions)； Spinal brake - unable to bend neck, or kyphotic deformity； Symptomatic dissection of the carotid siphon below； Common carotid artery opening lesion；present tracheotomy； Contralateral recurrent laryngeal nerve paralysis； Previously performed ipsilateral carotid endarterectomy，intracranial or subclavian arterial bypass surgery； Contralateral carotid artery occlusion； Lesions series； Severe long segment calcification of the carotid artery； Inaccessible lesions by endoluminal methods (Severe distortion of the aortic arch branch, no suitable introduction of arteries, aortic arch anatomy special）；
16. Investigators consider the patient inappropriate to participate in this clinical trial；
17. Those who participated in clinical trials of other drugs or medical devices before the inclusion did not reach the end of the time limit.
Angiography criteria
18. Severe vascular tortuosity, or anatomical conditions may affect the safe locomotion of guide catheter, guide sheath or stent；
19. Patients with ipsilateral carotid artery stenting or having a graft；
20. Patients with severe or extensive arteriosclerosis, involving the aortic arch and the proximal common carotid artery, causing locomotion danger of guide catheter or guide sheath；
21. Carotid endarterectomy contraindications by angiography：severity of intracranial or extracranial arterial stenosis that exceeds target lesions; cerebrovascular arteriovenous malformations; or other contraindications;
22. Patients with contralateral carotid artery stenosis, are expected to be performed within 30 days of the perioperative period of the study；
23. Occlusion.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Shanghai Changzheng Hospital
OTHER
China-Japan Friendship Hospital
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Xuanwu Hospital, Beijing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yong-Quan Gu
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
YongQuan Gu YQ Gu, Prof.
Role: PRINCIPAL_INVESTIGATOR
Xuanwu Hospital, Beijing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sino-Japanese Friendship Hospital
Beijing, , China
Shanghai Changhai Hospital
Shanghai, , China
Shanghai ChangZheng Hospital
Shanghai, , China
Zhongshan Hospital affiliated to Fudan University
Shanghai, , China
The first affiliated Hospital of Xi ' an Jiaotong University
Xi'an, , China
The first affiliated Hospital of Zhengzhou University
Zhengzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Peng Liu P Liu, Prof.
Role: primary
ZhiDong Ye ZD Ye
Role: backup
ZhiQing Zhao ZQ Zhao, Prof.
Role: primary
LeFeng Qu LF Qu, Prof.
Role: primary
DaQiao Guo DQ Guo, Prof.
Role: primary
JianLin Liu JL Liu, Prof.
Role: primary
Zhen Li Z Li, Prof.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007 Dec;6(12):1063-72. doi: 10.1016/S1474-4422(07)70274-0. Epub 2007 Nov 13.
North American Symptomatic Carotid Endarterectomy Trial Collaborators; Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, Fox AJ, Rankin RN, Hachinski VC, Wiebers DO, Eliasziw M. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 Aug 15;325(7):445-53. doi: 10.1056/NEJM199108153250701.
MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet. 1991 May 25;337(8752):1235-43.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
china carotid
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.